From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

NWOR
premium content

National World – considers possible offer proposal has “potential merits”, BUT…

Shares in ‘news media sector consolidator’ National World plc (NWOR) have traded below 18p since August-announced half-year results and most recently closed at 15p. However, there’s today “possible offer” news, so what of this and the shares currently around 18p in response?
Bearcast
premium content

Tom Winnifrith Bearcast: Hemogenyx you guys are taking the piss!

In today's podcast I discuss Mr Market and manic depression, Optibiotix (OPTI), Nostra terra (NTOG), Hemogenyx (HEMO), Webis (WEB), and Belluscura (BELL)
Clown
premium content

A failed fund manager offers his great thoughts on Jaguar and its relaunch

No not me silly. My own thoughts are explicit and HERE. But it seems that there is another failed fund manager of a similar vintage who has thoughts. I refer to disgraced Neil Woodford, still under FCA investigation, who writes...
NTOG
premium content

Nostra Terra is a great example of why the AIM market is dying and has been for some time

Anyone who has been investing or trading smaller market cap shares for any length of time will have noticed the demise of the AIM market, with liquidity flowing out; companies going bust and/or delisting; and even the pump and dumps getting fewer, further between, and with less impact when they do happen.
Bear

Video: The Darkening Skies Over Wall Street – Ominous Signals for Investors

Writer Jesse Felder is a cheery fellow, warning of a potentially lost decade for investors
SYME
premium content

Letter to the FCA demanding suspension of the trading in the shares of the technically insolvent Supply@ME Capital fraud

The letter is self explanatory and follows yesterday’s article HERE. I shall follow up with a note to the SEC over the weekend. The letter reads:
COA
premium content

Coats Group – “continued momentum with double-digit sales growth”, but still looks to offer value

‘The world’s leading industrial thread and global footwear component manufacturer’ Coats Group (COA) has issued a trading statement including that “in the four months to the end of October the group continued to perform well, led by Apparel and Footwear” and that it is confident in delivering a full year performance in line with expectations. The following is why that looks good news from a 94.6p share price.

Webis: Jim Mellon takes it private, in reality shareholders’ equity already worthless

A couple of days ago Webis (WEB) announced that it was taking a new, fourth loan, from Galloway, an entity wholly owned by my pal Jim Mellon. When fully drawn, Webis, which is loss making, will owe Galloway almost $3 million. Today Webis says it is to delist and leave AIM.
  • 13 hours ago |
Bearcast
premium content

Tom Winnifrith Bonus Bearcast: Now Lemming Junior says switch from Optibiotix to Skinbiotherapeutics

The note below shocks me in my naive way about payments made to the Lemming media empire by Optibiotix (OPTI), what a waste of money. I discuss why i am not sure switching right now is smart though I see the argument. The ball really is in the court of Steve O'Hara.
APH
premium content

Alliance Pharma – a recovery Buy?

In May this year consumer healthcare company Alliance Pharma (APH) faced audit-related results delay, its CEO leaving and was appealing a Competition and Markets Authority finding that it had infringed competition law and its fine. However, the subsequent half-year results suggest a much-improved picture but the shares have only currently recovered to a 46.8p offer price, which suggests to us significant further recovery potential.
LFT
premium content

BREAKING: Lift Global Ventures – deep dive into 30 June 2024 numbers, its off to the FRC I go!

Zak Mir's Lift Global Ventures (LFT) waited until late in the day Thursday to publish its annual report on its website so I have taken a deeper dive into its numbers. Lift has a structural problem in that even if you ignore the investments write offs of £750,000 in Trans Africa Energy and £67,106 of other mostly investment losses it still generated a loss of £159,046 on revenue of £476,506. So, its ongoing business is not sustainable as a public company because of the cost base.
Bearcast
premium content

Tom Winnifrith Bearcast: starting my hard conversation with Steve O' Hara

In today's podcast I look at Lift Global Ventures (LFT) where I have another treat for brown envelope man tomorrow, Supply@ME Capital (SYME), Optibiotix (OPTI), Victoria (VCP) and Nostra Terra (NTOG)
TFW
premium content

FW Thorpe – expects results “marginally ahead of last year”, but is such trading sufficient for the valuation?

Lighting systems company FW Thorpe (TFW) has issued an AGM trading statement including on its businesses that “Thorlux has started the year positively, as has Zemper” and “TRT is demonstrating some positive signs of improvement with a renewed sales team and new product introductions”. So what of a current group share price response more than 6% lower to 335p?
ECOB
premium content

Eco Buildings Group – letter of Intent for potential significant new contract, risk/reward Strong Buy

‘Modular housing’ group Eco Buildings (ECOB) has announced, following a visit to its manufacturing facility in Albania by a delegation from the Dominican Republic, “detailed negotiations have progressed positively, building on the Letter of Intent signed with Gramma Constructora SRL (a large private construction company headquartered in the Dominican Republic)” – this for a potential $237 million gross revenue contract to the group. What of an 18.5% increase in the share price to 8p in response, giving a market cap of just £6.5 million.
AAU
premium content

Ariana Resources – “Zenit Portfolio Operations Update”, the “portfolio” to expand?

Ariana Resources (AAU) has issued a “Zenit Portfolio Operations Update.” ‘Zenit’ is the company’s joint venture interests in Turkey in which it has a 23.5% interest, though the announcement also includes that Ariana is “currently positioning ourselves to expand our partnership into new jurisdictions”. That is potentially very exciting.
JD
premium content

JD Sports Fashion – emphasises “well positioned for peak season”… but even with that only expects ‘lower end of guidance range’!

“Sports, fashion and outdoor brands” retailer JD Sports Fashion (JD.) has issued a trading update for its third quarter to 2nd November 2024 headlined “Strong margin management in volatile market; well positioned for peak season”. So what of a current share price response more than 10% lower towards 100p?
Clown
premium content

#Gowokegobroke: Jaguar and its new advert

Most purchasers of Jaguar cars are older men, the vast majority of whom will be straight. Folks like me who think fondly of Inspector Morse and his Motor. I suspect folks like me are in short supply in the Jaguar marketing department which will be stuffed full of all sorts of diverse young folks with liberal arts degrees. And they have served up the advert below as part of a "rebranding". There is already a backlash. Sales will fall. It will be withdrawn. Nobody will be fired. Life goes on.
Bearcast
premium content

Tom Winnifrith bonus bearcast: Which accounts from Zak Mir are a tissue of lies?

Lift Global Ventures (LFT) run by brown envelope man has issued diabolical, red flag strewn accounts. But which set of accounts for its main subsidiary are a tissue of lies and is Zak a tax dodger?
SDY
premium content

Speedy Hire – interims, “the board anticipates the group meeting its full year expectations”. Really?…

Most recently writing on Speedy Hire (SDY), which describes itself as “the UK's leading tools and equipment hire services company”, last month with the shares down to 36p I questioned how confident to really be in its “anticipates the group meeting its full year expectations”. What of now results for its half-year ended 30th September 2024 and a currently further down below 30p share price?

CEL
premium content

Celadon Pharmaceuticals: FFS just come clean, when’s the massively discounted placing?

As a long term bear the near death throes of Celadon Pharmaceuticals (CEL) provide some morbid satisfaction but there is a way of, at least postponing, the grim end and that is a placing. It will be massively discounted but Celadon needs to come clean, fess up and do it before it’s too late.
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

Time left: 23:42:43